Download PDF
1 / Pages

Other users also viewed these articles

Impact of systemic therapies on SARS-CoV-2 antibody seroprevalence in patients with immune-mediated diseases Liz Romero-Bogado; Martina Steiner; Israel John Thuissard Vasallo; Cristina Andreu Vázquez; Teresa Navío; Santiago Muñoz-Fernández;
Med Clin. 2024;162:470-6
Influence of angiotensin receptor and converting enzyme blockers therapy in the respiratory outcome of COVID-19 hospitalized patients Felipe B. Lima; Francisco Wilker Mustafa Gomes Muniz; Gdayllon C. Meneses; Karine C. Bezerra; Carolyne N. Moreira; André P. Aguiar; José Carlos R. Nascimento; Tainá Veras de S. Freitas; Pedro Felipe C. de Bruin; Eanes Delgado B. Pereira; Elizabeth de F. Daher; Reinaldo B. Oriá;
Med Clin. 2024;162:163-9
Impact of SARS-CoV-2 infection in patients with cardiac amyloidosis: Results of a multicentre registry José M. Larrañaga-Moreira; Ana I. Rodriguez-Serrano; Fernando Domínguez; Andrea Lalario; Esther Zorio; Roberto Barriales-Villa;
Med Clin. 2023;161:476-82